http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI1003970-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6085cc981958ccb9f6c9c0b5ead9f539 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-02 |
| filingDate | 2010-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4268c052448b6c260fc385eeab5e59e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_968668a70802247a278c8bf84561a3e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf40d8ed89eaa18f0dc0618e2f2980cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d5fa9eae30ff5f9b8b7b078c8587edd |
| publicationDate | 2012-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI1003970-A2 |
| titleOfInvention | radionuclide labeling process for murine or human monoclonal or polyclonal anti-tumor necrosis factor-associated antibodies to diseases whose pathophysiology involves tumor necrosis factor; "in vivo" and / or "in vitro" diagnostic reagent based on murine or human, monoclonal or polyclonal anti-tumor necrosis factor-associated antibodies to radionuclides; "In vitro" and / or "in vivo" diagnostic methods for diseases whose pathophysiology involves tumor necrosis factor using the reagent thus obtained and a kit for the diagnosis of diseases whose pathophysiology involves tumor necrosis factor based on said reagent |
| abstract | MARKING PROCESS WITH RADIONUCLIDS OF MURINE OR HUMAN, MONOCLONAL OR POLYCONAL ANTI-FACTOR OF TUMOR NECROSIS DISEASES ASSOCIATED WITH DISEASES WHOSE TUMOR NECROSIS FACTOR; REAGENT FOR "IN VIVO" AND / OR "IN VITRO" DIAGNOSIS BASED ON RADIONUCLIDE-RELATED ANTI-FACTOR OR HUMAN, HUMAN, HUMAN, OR POLYCLONAL ANTI-FACTOR ANTIBODIES; "IN VITRO" AND / OR "IN VIVO" DIAGNOSTIC DIAGNOSIS METHODS OF WHICH PHYSIOPATHOGENIA INVOLVES TUMORAL NECROSIS FACTOR USING THE REAGENT AS OBTAINED AND KIA FOR DISEASE DIAGNOSIS DEVELOPMENT OF THE FISIOPATHY. The present invention relates to a radionuclide labeling process for murine or human, monoclonal or polyclonal anti-tumor necrosis factor antibodies, as well as to the in vivo or in vitro diagnostic reagent based on anti-cancer antibodies. murine or human radionuclide-labeled monoclonal or polyclonal tumor necrosis factor, their use for diagnosis, the in vitro and in vivo diagnostic method of diseases whose pathophysiology involves the tumor necrosis factor and the diagnostic kit of immunological diseases using said reagent. |
| priorityDate | 2010-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.